EUVIMEDEUVIMED entdecken
Multizentrische Studie

SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study

Guarina Angela, Giordano Paola, Lassandro Giuseppe, Ramenghi Ugo, Saracco Paola, Farinasso Loredana, Bombaci Sabrina, Tasca Sofia, Notarangelo Lucia Dora, Gorio Chiara, Miano Maurizio, Massaccesi Erika und 19 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70448 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Guarina Angela und 30 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Onco-Hematology Unit, A.R.N.A.S. Civico Hospital, Palermo, Italy. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, COVID-19 Vaccines, COVID-19, Vaccination. Die Arbeit nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune thrombocytopenia (ITP) is the most common acquired bleeding disorder in childhood. Although viral infections and some vaccinations are recognized triggers, data on the onset or exacerbation of ITP following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination in pediatric patients remain limited.

Objectives

To evaluate the incidence and clinical characteristics of new‐onset ITP and the safety of SARS‐CoV‐2 vaccination in children with preexisting or resolved ITP.

Methods

We evaluated the incidence and clinical characteristics of ITP occurring after SARS‐CoV‐2 vaccination, as well as the effects of vaccination in children with preexisting ITP.

Results

De novo ITP: five cases of new‐onset ITP were identified nationwide, most of which occurred after the first vaccine dose (80%). Despite low median platelet counts at presentation, no major or fatal bleeding events were observed. Most patients responded favorably to first‐line treatments (intravenous immunoglobulins and/or corticosteroids), and 80% achieved normal platelet counts at the last follow‐up. Preexisting ITP: among 164 vaccinated patients with complete clinical data, only 8.5% ( n = 14) experienced a transient platelet count decline or new bleeding manifestations. Notably, no relapses occurred among the 34 patients who were in clinical remission at the time of vaccination.

Conclusions

ITP following SARS‐CoV‐2 vaccination in the pediatric population is exceedingly rare and generally mild. Moreover, SARS‐CoV‐2 vaccination appears safe in children with preexisting or resolved ITP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicCOVID-19 VaccinesCOVID-19VaccinationSARS-CoV-2HumansFemaleMaleChildChild, PreschoolInfantAdolescentIncidencePlatelet CountImmunoglobulins, Intravenous

Stichwörter der Autor:innen

childrenimmunesevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)thrombocytopeniavaccination

Substanzen

COVID-19 VaccinesImmunoglobulins, Intravenous

Autor:innen und Institutionen

  • Pediatric Onco-Hematology Unit, A.R.N.A.S. Civico Hospital, Palermo, Italy.
  • Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
  • Department of Public Health and Pediatric Sciences, Regina Margherita Children's Hospital, University of Turin, Turin, Italy.
  • Medical Direction, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
  • Pediatric Onco-Hematology Unit, Children's Hospital, ASST-Spedali Civili, Brescia, Italy.
  • Hematology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Zitieren

APA

Angela, G., Paola, G., Giuseppe, L., Ugo, R., Paola, S., Loredana, F., Sabrina, B., Sofia, T., Dora, N. L., Chiara, G., Maurizio, M., Erika, M., Barbara, B., Irene, D., Angelica, B., Ilaria, F., Giuseppe, P., Gianluca, B., Federico, V., …, & Piero, F. (2026). SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70448

Vancouver

Angela G, Paola G, Giuseppe L, Ugo R, Paola S, Loredana F, et al. SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70448

BibTeX
@article{Angela2026,
  author = {Angela, Guarina and Paola, Giordano and Giuseppe, Lassandro and Ugo, Ramenghi and Paola, Saracco and Loredana, Farinasso and Sabrina, Bombaci and Sofia, Tasca and Dora, Notarangelo Lucia and Chiara, Gorio and Maurizio, Miano and Erika, Massaccesi and Barbara, Bruschi and Irene, D'Alba and Angelica, Barone and Ilaria, Fontanili and Giuseppe, Palumbo and Gianluca, Boscarol and Federico, Verzegnassi and Simone, Cesaro and Agnese, Corbelli and Silverio, Perrotta and Maddalena, Casale and Francesca, Rossi and Mariamaddalena, Marrapodi and Antonio, Ruggiero and Alberto, Romano and Saverio, Ladogana and Angela, Maggio and Giovanna, Russo and Piero, Farruggia},
  title = {SARS‐CoV‐2 Vaccination and Immune Thrombocytopenia in Children: A Multicenter Study},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70448}
}
Kostenlos starten →